NBIX - Neurocrine launches CAH community website ahead of FDA filing
2024-04-24 19:08:44 ET
More on Neurocrine Biosciences
- Neurocrine Biosciences Heads Into A Catalyst-Rich 2024 With Additional Upside
- Neurocrine Biosciences (NBIX) Q4 2023 Earnings Call Transcript
- Neurocrine Biosciences upgraded at Wells Fargo on pipeline
- Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug
- Seeking Alpha’s Quant Rating on Neurocrine Biosciences